vs
DYNEX CAPITAL INC（DX）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
STEM, INC.的季度营收约是DYNEX CAPITAL INC的1.1倍（$47.1M vs $43.5M），DYNEX CAPITAL INC同比增速更快（531.3% vs -15.6%），过去两年DYNEX CAPITAL INC的营收复合增速更高（75.8% vs 36.1%）
Dynex Capital Inc是一家总部位于美国的上市房地产投资信托公司，专注于投资和管理抵押贷款支持证券、住宅及商业抵押贷款等各类抵押相关资产组合，通过稳健运营为股东创造稳定分红和长期资本增值。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
DX vs STEM — 直观对比
营收规模更大
STEM
是对方的1.1倍
$43.5M
营收增速更快
DX
高出546.9%
-15.6%
两年增速更快
DX
近两年复合增速
36.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $43.5M | $47.1M |
| 净利润 | — | $-16.0M |
| 毛利率 | — | 48.9% |
| 营业利润率 | — | -17.7% |
| 净利率 | — | -33.9% |
| 营收同比 | 531.3% | -15.6% |
| 净利润同比 | — | 68.8% |
| 每股收益（稀释后） | $1.59 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXSTEM
| Q4 25 | $43.5M | $47.1M | ||
| Q3 25 | $30.6M | $38.2M | ||
| Q2 25 | $23.1M | $38.4M | ||
| Q1 25 | $17.1M | $32.5M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | — | $29.3M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | $-3.2M | $25.5M |
净利润DXSTEM
| Q4 25 | — | $-16.0M | ||
| Q3 25 | $150.4M | $-23.8M | ||
| Q2 25 | $-13.6M | $202.5M | ||
| Q1 25 | $-3.1M | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | — | $-148.3M | ||
| Q2 24 | — | $-582.3M | ||
| Q1 24 | $40.1M | $-72.3M |
毛利率DXSTEM
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
营业利润率DXSTEM
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
净利率DXSTEM
| Q4 25 | — | -33.9% | ||
| Q3 25 | 491.3% | -62.2% | ||
| Q2 25 | -58.8% | 527.8% | ||
| Q1 25 | -18.0% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | — | -506.3% | ||
| Q2 24 | — | -1712.6% | ||
| Q1 24 | -1256.8% | -283.9% |
每股收益（稀释后）DXSTEM
| Q4 25 | $1.59 | $-4.40 | ||
| Q3 25 | $1.08 | $-2.84 | ||
| Q2 25 | $-0.14 | $-1.79 | ||
| Q1 25 | $-0.06 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | — | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | $0.64 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $531.0M | $48.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.5B | $-249.4M |
| 总资产 | $17.3B | $308.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXSTEM
| Q4 25 | $531.0M | $48.9M | ||
| Q3 25 | $491.0M | $43.1M | ||
| Q2 25 | $387.5M | $40.8M | ||
| Q1 25 | $327.4M | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | $295.7M | $112.8M |
股东权益DXSTEM
| Q4 25 | $2.5B | $-249.4M | ||
| Q3 25 | $2.0B | $-235.7M | ||
| Q2 25 | $1.6B | $-214.1M | ||
| Q1 25 | $1.4B | $-417.5M | ||
| Q4 24 | — | $-398.4M | ||
| Q3 24 | — | $-344.1M | ||
| Q2 24 | — | $-203.2M | ||
| Q1 24 | $958.5M | $371.6M |
总资产DXSTEM
| Q4 25 | $17.3B | $308.9M | ||
| Q3 25 | $14.2B | $362.6M | ||
| Q2 25 | $11.3B | $379.2M | ||
| Q1 25 | $9.0B | $405.1M | ||
| Q4 24 | — | $437.4M | ||
| Q3 24 | — | $537.8M | ||
| Q2 24 | — | $691.5M | ||
| Q1 24 | $6.3B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $120.8M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DXSTEM
| Q4 25 | $120.8M | $8.2M | ||
| Q3 25 | $68.3M | $11.4M | ||
| Q2 25 | $31.9M | $-21.3M | ||
| Q1 25 | $6.4M | $8.5M | ||
| Q4 24 | — | $-14.7M | ||
| Q3 24 | — | $-9.4M | ||
| Q2 24 | — | $-11.9M | ||
| Q1 24 | $-17.1M | $-621.0K |
现金转化率DXSTEM
| Q4 25 | — | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
